SMYD3 and non-small cell lung carcinoma: In non-small cell lung cancer, SMYD3 binds to the anoctamin-1 (ANO1) promoter region, which is enriched with H3K4me3, thereby increasing ANO1 transcription and regulating cancer cell proliferation74.